CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Dev., Operating Officer Jeff E. Knight sold $3.4M of Crinetics Pharmaceuticals, Inc.
Sold$3,415,036
$40.10Price
85,163Shares
−45%Stake
What CRNX did after the filing
- The stock from Mon, Apr 13 open, $39.18
- −6.1%
- S&P 500, same days
- +10.8%
Measured over 30 trading days, to the May 26 close.
Traded Wed, Apr 8. Filed Fri, Apr 10, 4:33 PM ET, after the close. Returns use the Apr 13 open and the May 26 close. Not investment advice.